C

Checkpoint Therapeutics
D

CKPT

4.12000
USD
0.00
(0.00%)
مغلق
حجم التداول
32,670
الربح لكل سهم
0
العائد الربحي
-
P/E
-3
حجم السوق
358,522,408
أصول ذات صلة
ABBV
ABBV
5.160
(2.67%)
198.440 USD
AZN
AZN
1.940
(2.75%)
72.440 USD
BMY
BMY
1.000
(2.02%)
50.560 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
GSK
GSK
-0.120
(-0.31%)
39.070 USD
JNJ
JNJ
1.720
(1.11%)
156.120 USD
LLY
LLY
10.33
(1.27%)
823.96 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
NVS
NVS
3.000
(2.69%)
114.320 USD
PFE
PFE
0.065
(0.27%)
24.185 USD
المزيد
الأخبار المقالات

العنوان: Checkpoint Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patientswith solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.